Rigel Pharmaceuticals
The Senior Director, Program Management is a senior cross-functional leader responsible for moving complex drug development programs from strategy to execution. This role connects plans across clinical, regulatory, CMC, nonclinical, and commercial functions to build integrated timelines, identify risks, and drive follow-through. The position requires a deep understanding of drug development to contribute meaningfully to program discussions and challenge assumptions.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
1996
Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing, and providing novel therapies that significantly improve the lives of patients with hematologic disorders and cancer. The company markets approved products including TAVALISSE, REZLIDHIA, and Gavreto, and maintains a pipeline of clinical programs including IRAK1/4 and RIPK1 inhibitors. Rigel is publicly traded under the ticker RIGL and is headquartered in South San Francisco, California.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rigel Pharmaceuticals.
61% above the average for this role
Senior Manager / Associate Director, CMC Project Management
Pulmovant
Associate Director, Program Management
Seaport Therapeutics
Director of Program Management
Septerna
Associate Director of Program Management
RayzeBio
Director, Program Management
Moderna
Senior Manager, Development Program Management
Regeneron Pharmaceuticals